Targeted delivery of paclitaxel to EphA2-expressing cancer cells
about
Targeting the Eph System with Peptides and Peptide ConjugatesNovel delivery approaches for cancer therapeutics.Combinatorial peptide libraries: mining for cell-binding peptides.AIEgen-based theranostic system: targeted imaging of cancer cells and adjuvant amplification of antitumor efficacy of paclitaxelMicroRNA applications for prostate, ovarian and breast cancer in the era of precision medicine.Design, synthesis and bioevaluation of an EphA2 receptor-based targeted delivery system.Decreased expression of receptor tyrosine kinase of EphB1 protein in renal cell carcinomas.Ephrin type‑A receptor 2 regulates sensitivity to paclitaxel in nasopharyngeal carcinoma via the phosphoinositide 3‑kinase/Akt signalling pathwayThe novel desmopressin analogue [V4Q5]dDAVP inhibits angiogenesis, tumour growth and metastases in vasopressin type 2 receptor-expressing breast cancer models.Design and Characterization of Novel EphA2 Agonists for Targeted Delivery of Chemotherapy to Cancer Cells.Tumor-targeting peptides from combinatorial libraries.Necrosis-inducing peptide has the beneficial effect on killing tumor cells through neuropilin (NRP-1) targeting.Peptides in receptor-mediated radiotherapy: from design to the clinical application in cancers.Eph receptors and ephrins: therapeutic opportunities.Combination Approach of YSA Peptide Anchored Docetaxel Stealth Liposomes with Oral Antifibrotic Agent for the Treatment of Lung Cancer.Design and Synthesis of Potent Bivalent Peptide Agonists Targeting the EphA2 ReceptorTherapy of pancreatic cancer via an EphA2 receptor-targeted delivery of gemcitabine.Expression of the EPHB4 receptor tyrosine kinase in head and neck and renal malignancies--implications for solid tumors and potential for therapeutic inhibition.Reduction of Circulating Cancer Cells and Metastases in Breast-Cancer Models by a Potent EphA2-Agonistic Peptide-Drug Conjugate.
P2860
Q26799461-6829E9E4-F7BE-4113-B30D-F784F0A1CDF2Q30368171-273599CC-B397-4FD2-8BA9-0263E6C5A65EQ31144876-FA0E72E3-A3F3-492F-8427-8675066A6EE7Q33609659-7EAEC817-92E9-4AB1-A319-CD9A1A4DA6F5Q33733403-8EA614A9-E7CD-4D04-BAE6-612164391100Q33848124-723C62C3-7CBB-4951-9C3D-1AC8FED990B0Q34029227-D07AF04E-6F22-41FB-94AA-DB9DB2535332Q34673530-898A799A-E6FA-4AD5-B75D-55E2CA75C7F1Q35636438-4074B459-32E4-4838-B4E7-D52D1F33FFB8Q35889278-F35CA888-63CA-4904-8F93-C8A29FD4A19FQ36025723-AABE41F6-E9F7-480B-A4E5-025A9829EC04Q37362688-58E6230F-28B1-497F-B114-BDA88F43B6D5Q38149131-296727E6-D538-4C8A-B0AD-8C8D614EC71FQ38257853-AA31B650-76A4-40F2-A97A-0B91A8ED36E1Q38778869-ECD9BB90-6EB6-4E83-A838-AB331080C6E6Q41915374-18C17A9E-5AC9-4417-A03B-960C4D78FE2AQ41954025-A5F3BAD4-B02F-43A4-9405-7D31E949FCA8Q43083986-D07B9864-48C2-4F56-BABE-31C7EA22A863Q51749008-CCC8256E-56BD-4D5C-A16B-B0ACBF7A9BE8
P2860
Targeted delivery of paclitaxel to EphA2-expressing cancer cells
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Targeted delivery of paclitaxel to EphA2-expressing cancer cells
@ast
Targeted delivery of paclitaxel to EphA2-expressing cancer cells
@en
type
label
Targeted delivery of paclitaxel to EphA2-expressing cancer cells
@ast
Targeted delivery of paclitaxel to EphA2-expressing cancer cells
@en
prefLabel
Targeted delivery of paclitaxel to EphA2-expressing cancer cells
@ast
Targeted delivery of paclitaxel to EphA2-expressing cancer cells
@en
P2093
P2860
P1476
Targeted delivery of paclitaxel to EphA2-expressing cancer cells
@en
P2093
Ana Fernandez
Elena B Pasquale
John L Stebbins
Maurizio Pellecchia
Neil A Bhowmick
Paul B Fisher
Roberta Noberini
Sandrine Billet
Sayantan Mitra
P2860
P304
P356
10.1158/1078-0432.CCR-12-2654
P407
P577
2012-11-15T00:00:00Z